Skip to content ↓

Topic

Diagnostics

Download RSS feed: News Articles / In the Media

Displaying 1 - 15 of 20 news clips related to this topic.
Show:

The Washington Post

MIT researchers are developing innovations aimed at improving Covid-19 diagnostics, including an atomic-level test designed to increase testing accuracy, reports Steven Zeitchik for The Washington Post. Professor James Collins and his team are developing “a mask that uses freeze-dried technology to detect the coronavirus.”

CBS Boston

A new tabletop device developed by researchers from MIT and other institutions can identify Covid-19 variants in a person’s saliva, reports CBS Boston. “We tried to limit the number of user steps to make sure it was as easy as possible,” explains graduate student Devora Najjar.

Popular Mechanics

Popular Mechanics reporter Courtney Linder spotlights how Prof. Alfredo Alexander-Katz is developing a “rapid antigen Covid-19 test that can accurately detect viral proteins in just minutes.”

WBUR

WBUR’s Carey Goldberg chronicles how the Broad Institute of MIT and Harvard is processing over 70,000 Covid-19 tests a day for Massachusetts nursing homes, hot spots and over 100 colleges. Goldberg notes that the Broad’s testing capacity, “is now allowing thousands of college students to be on campus across the region.”

GBH

Prof. Sinan Aral speaks with GBH’s Arun Rath about his study showing that a lack of coordination between states on their reopening plans can lead to an influx in Covid-19 cases. Rath also spotlights the Broad Institute’s work processing over 1.5 million diagnostic tests for coronavirus since March 25.

Scientific American

Writing for Scientific American, Carolyn Barber spotlights how researchers from MIT are developing cheap, fast and easy to use diagnostics for Covid-19 that can deliver results in minutes. “They are called lateral flow assays, but manifestly they are paper-strip tests that have an antibody embedded on filter paper,” writes Barber. “If a saliva sample has coronavirus present, the antibody will bind that viral antigen, turning the test positive, much like a pregnancy test works.”

WHDH 7

WHDH spotlights MIT startup E25Bio, which is developing a new rapid test to diagnose Covid-19. The test being developed by E25Bio is a paper strip that can deliver test results in 15 minutes, WHDH explains.

Marketplace

Prof. James Collins speaks with Molly Wood of Marketplace about his work developing a faster, cheaper and more accurate Covid-19 diagnostic. Collins explains that his research group is “using synthetic biology to create highly sensitive, low-cost diagnostics, some that are now approved for use in clinical diagnostics labs, and now we’re moving towards point-of-care diagnostics, as well as at-home diagnostics.”

USA Today

Reporting for USA Today, Karen Weintraub spotlights how researchers from MIT and 3M are collaborating on a rapid, low-cost diagnostic test for Covid-19. "The world needs as many useful tests as possible as fast as possible," says Prof. Hadley Sikes.

Stat

Prof. Sangeeta Bhatia and senior postdoctoral associate Leslie Chan discuss their work developing a synthetic biosensor to diagnose lung disease. Chan explains that “instead of relying on naturally occurring breath volatiles, we wanted to be able to engineer the breath signal that we could use to monitor lung disease.”

CNBC

CNBC reporter Will Feur spotlights how researchers from MIT are working with 3M on developing a rapid coronavirus antigen test. The test “will be a paper-based point-of-care testing device, which will help reduce the cost,” Feur explains.

Reuters

Researchers from MIT and 3M are developing a new rapid antigen test for Covid-19, reports Carl O’Donnell for Reuters. “The test would produce results within minutes and could be administered on a low-cost, paper-based device, similar to a home pregnancy test, that could be delivered at the point of care,” writes O’Donnell.

TechCrunch

TechCrunch reporter Darrell Etherington writes that researchers from MIT and 3M are working on creating a new diagnostic tool for Covid-19 that can be manufactured cheaply and in large volumes for mass distribution. “The goal is to create a test that detects viral antigens,” Etherington explains, adding that the tests “provide results much faster than the molecular PCR-based test.”

Amy Dockser Marcus of The Wall Street Journal writes about the growing interest in using CRISPR as a diagnostic tool, which led to a collaboration between MIT Professors James Collins and Feng Zhang. The result is Sherlock, a diagnostic platform that can identify viruses “based on extremely low amounts of RNA in blood and urine samples,” explains Dockser Marcus.

Boston 25 News

FOX 25’s Bob Dumas reports on a study by MIT Medical that shows most parents could successfully perform strep tests at home. David Diamond, associate medical director of MIT Medical, explains that in the healthcare field, “we are empowering patients to help us take care of their health,” adding that this test, “would be yet another advance in this regard.”